Adaptive Biotechnologies Corporation Cash Conversion Cycle 2011-2025 | ADPT

Annual Cash Conversion Cycle Adaptive Biotechnologies Corporation

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
101	115	127	132	167	130	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
167	101	129

Quarterly Cash Conversion Cycle Adaptive Biotechnologies Corporation

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
46.2	77.8	83.6	-	96.9	92.6	107	-	134	118	135	-	65.7	75.5	154	-	109	145	141	-	198	245	181	-	120	126	160	-	128	73.6	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
245	46.2	122

Cash Conversion Cycle of other stocks in the Biotechnology industry

Issuer	Cash Conversion Cycle	Price	% 24h	Market Cap	Country
Arbutus Biopharma Corporation ABUS	31.5	$ 4.8	2.46 %	$ 797 M	Canada
Aclaris Therapeutics ACRS	-881	$ 3.05	5.17 %	$ 236 M	USA
Aptevo Therapeutics APVO	-47.4	$ 0.93	-8.45 %	$ 257 K	USA
Catalyst Biosciences CBIO	391	$ 12.37	2.02 %	$ 814 M	USA
Alexion Pharmaceuticals, Inc. ALXN	12.8	-	-	$ 40.3 B	USA
EyeGate Pharmaceuticals, Inc. EYEG	17	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	82.8	-	-18.52 %	$ 27.3 M	Britain
Celldex Therapeutics CLDX	-6.08 K	$ 26.69	0.41 %	$ 1.72 M	USA
Corcept Therapeutics Incorporated CORT	-186	$ 83.84	2.26 %	$ 8.65 B	USA
Catalyst Pharmaceuticals CPRX	54.2	$ 24.34	0.45 %	$ 2.88 B	USA
CorMedix CRMD	-215 K	$ 12.02	0.3 %	$ 612 M	USA
Институт стволовых клеток человека ISKJ	104	-	-	-	Russia
Acasti Pharma ACST	1.97	-	4.01 %	$ 150 M	Canada
Adaptimmune Therapeutics plc ADAP	25	-	-15.15 %	$ 60.3 M	Britain
Albireo Pharma ALBO	-1.55 K	-	-0.23 %	$ 916 M	USA
Alpine Immune Sciences ALPN	154	-	-	$ 2.17 B	USA
Ampio Pharmaceuticals AMPE	-2.85 K	-	-11.43 %	$ 502 K	USA
Amphastar Pharmaceuticals AMPH	166	$ 26.97	1.97 %	$ 1.31 B	USA
Anika Therapeutics ANIK	270	$ 9.49	1.06 %	$ 139 M	USA
Eton Pharmaceuticals ETON	-6.66	$ 17.08	3.17 %	$ 438 M	USA
Exelixis EXEL	5.31	$ 46.72	0.24 %	$ 13.6 B	USA
Arena Pharmaceuticals ARNA	946	-	-6.81 %	$ 3.04 B	USA
Axon Enterprise AXON	86.2	$ 588.51	-0.42 %	$ 44.6 B	USA
Ayala Pharmaceuticals AYLA	-2.15 K	-	-	$ 7.46 M	Israel
Aytu BioScience AYTU	174	$ 2.5	-1.77 %	$ 15.7 M	USA
AstraZeneca PLC AZN	-58	$ 92.33	0.21 %	$ 96.9 B	Britain
Acorda Therapeutics ACOR	117	-	-24.86 %	$ 820 K	USA
Brickell Biotech BBI	149	-	-5.38 %	$ 6.06 M	USA
BeiGene, Ltd. BGNE	49.5	-	0.49 %	$ 251 B	Cayman-islands
Biohaven Pharmaceutical Holding Company Ltd. BHVN	209	$ 10.64	1.33 %	$ 688 M	USA
Biogen BIIB	387	$ 176.8	1.13 %	$ 25.7 B	USA